Overview: HB 4814, Insurance: health insurers; coverage for treatment of menopause and perimenopause symptoms and waiver of prior authorization for prescription drugs or treatments for menopause and perimenopause symptoms; require, bill electronically reproduced 08/26/2025, Introduced on March 13, 2025.
Purpose and Intent: The primary goal of this bill is to require health insurance providers in Michigan to cover the treatment of menopause and perimenopause symptoms, as well as to waive prior authorization requirements for related prescription drugs or treatments.
Key Provisions:
- Mandates that health insurance plans provide coverage for the diagnosis, management, and treatment of menopause and perimenopause symptoms, including hormone therapy, non-hormonal therapies, and other medically necessary treatments.
- Requires health insurers to waive any prior authorization requirements for prescription drugs or treatments related to menopause and perimenopause symptoms.
- Prohibits health insurers from denying, limiting, or imposing additional cost-sharing for these covered services.
Affected Parties and Impacts: This bill would directly benefit individuals experiencing menopause or perimenopause symptoms by ensuring access to necessary medical care and treatments through their health insurance plans. It aims to improve the quality of life and overall health outcomes for those going through these natural life transitions.
Procedural and Timeline Considerations: HB 4814 has been electronically reproduced and is currently in the legislative process. The next step would be for the bill to be referred to a committee for further review and potential amendments before moving to a full vote in the House of Representatives.
